Analyst Research Report Snapshot

Title:

ADMA: 4Q13: 2014 will be the key year with major catalyst toward year-end; reiterating Buy rating and a 12-month price target of $15.00

Price:

$25.00

Provider:

Laidlaw & Company

Date:

01 Apr 2014

Pages:

8

Type:

AcrobatPDF

Companies referenced:

ADMA.OB

Available for Immediate Download
Summary:

ADMA reported 4Q13 financial results with a net loss of ($4.7MM), or ($0.55) net loss per share. For the 2014 full year, net losses were ($15.5MM), or ($2.38) net loss per share. With cash of ~$29MM by year-end 2013, we believe the company has sufficient capital for operations entering 2016. We are reiterating our Buy rating and our $15 target price to reflect the continued execution of corporate developments, including completion of the RI-002 Phase III study and expansion of additional plasma collection centers.

Why buy analyst research?

  • Institutional quality research
  • Available for Immediate Download
  • Detailed company or industry insight
  • Print or save
  • 24 hour customer support
Return to previous page without adding this item to your cart.
Email Customer Support.

About Analyst Research

Analyst research reports are available for immediate download after purchase. You will have unlimited access to the report for 24 hours after purchase, to download, print or save it as many times as you wish. Analyst Research provided by Reuters does not constitute investment advice, and is not endorsed by Reuters Research. This information is protected by copyright and intellectual property laws. More information on Analyst Research.